Studies have shown that in other pathological conditions, such as myocardial fibrosis in AF, which is attributed to the neurohumoral activation effect, the level of Smad7 is down-regulated (He et al., 2016). This evidence concerns the gene SMAD7 and Myocardial fibrosis.